Product Description: Nemonoxacin (TG-873870) malate is a nonfluorinated quinolone antibiotic. Nemonoxacin malate has broad-spectrum activity against Gram-positive, Gram-negative and atypical pathogens. Nemonoxacin malate can inhibit drug-resistant Streptococcus pneumoniae and (HY-121544) Methicillin-resistant Staphylococcus aureus. Nemonoxacin malate can be used for the research of community-acquired pneumonia[1][2].
Applications: COVID-19-immunoregulation
Formula: C24H31N3O9
References: [1]Chotikanatis K, et al. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother. 2014;58(3):1800-1./[2]Lai CC, et al. Nemonoxacin (TG-873870) for treatment of community-acquired pneumonia. Expert Rev Anti Infect Ther. 2014 Apr;12(4):401-17.
CAS Number: 951163-60-3
Molecular Weight: 505.52
Compound Purity: 99.43
Research Area: Infection
Solubility: DMSO : 100 mg/mL (ultrasonic)/H2O : 25 mg/mL (ultrasonic)
Target: Antibiotic;Bacterial
English
Deutsch
